Analysts' Actions: HD SBUX MUR WAG CVS


Apogee Enterprises ( APOG) downgraded to hold at TheStreet Ratings.

Bridge Bancorp ( BDGE) downgraded to hold at TheStreet Ratings.

Celanese ( CE) downgraded at Dahlman Rose to Hold, Dahlman Rose said. Company is leveraged to slower growth in Asia and Europe.

Cooper Cos. ( COO) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $96 price target. Stock has pulled back but the company should deliver solid results in the second half of the year.

CVS Caremark ( CVS) rated new Buy at Cantor. $55 price target. Earnings should improve across the board in the coming quarters.

Entergy ( ETR) downgraded at BofA/Merrill to Underperform, Bank of America/Merrill Lynch said. $70 price target. Estimates also cut, given regulatory risk.

Five Below ( FIVE) rated new Buy at Deutsche Bank. $40 price target. Company can continue to deliver solid growth.

Francesca's ( FRAN) rated new Buy at Janney Montgomery. $38 price target. Company can continue to expand store count and sales per location.

Walgreen ( WAG) rated new Buy at Cantor Fitzgerald. $43 price target. ESRX resolution removes a key overhang.


Dick's Sporting Goods ( DKS) numbers raised at Citigroup. Shares of DKS now seen reaching $58, Citigroup said. Estimates also increased on improved 2H outlook. Buy rating.

Exelon ( EXC) numbers lowered at Jefferies. Shares of EXC now seen reaching $42, Jefferies said. Estimates also lowered on depressed prices for the foreseeable future. Buy rating.

Home Depot ( HD) numbers increased at BMO. HD estimates were raised through 2013, BMO Capital said. Company is seeing higher sales and keeping a tight lid on costs. Market Perform rating and new $54 price target.

Home Depot target raised at Jefferies to $51. Market optimism is growing. Hold rating.

Intermune ( ITMN) numbers cut at UBS. Shares of ITMN now seen reaching $8.50, UBS said. Estimates also lowered to reflect Esbriet pricing and sales. Neutral rating.

Michael Kors ( KORS) numbers raised at Nomura. Shares of KORS now seen reaching $54, according to Nomura. Estimates also increased, as the company is realizing higher sales and margins. Buy rating.

Marathon Oil ( MRO) numbers lowered at Oppenheimer. Shares of MRO now seen reaching $35, Oppenheimer said. Estimates also lowered on lower crude prices. Outperform rating.

If you liked this article you might like

Look Back to Go Forward

You Are Forgetting This Commonsense Investing Wisdom

Cramer: Irma and Harvey Busted the Algos

First Leg Down of United Tech; Hurricanes -- Jim Cramer's Top Thoughts

Cheaper as They Slide; Tax Reform -- Jim Cramer's Top Thoughts